Effects of Virtual Reality on Brain Hemodynamic Activity in Chronic Pain
NCT ID: NCT06154850
Last Updated: 2024-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2023-11-07
2024-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is predicted that the integration of virtual reality methods into treatment protocols will gradually increase by time, especially as a result of the reflection of technological developments in clinical practice. At this point, fNIRS, which enables the assessment of the functionality of brain areas during movement, has the potential to reveal the response of the effect provided by virtual reality technology in the prefrontal cortex.
The aims of our study were to examine brain hemodynamic activity during the experience of non-immersive and immersive virtual reality environments and the change in pain intensity after virtual reality applications in individuals with rheumatic diseases with chronic pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
NCT04851301
Virtual Realityon Pain, Anxiety and Comfort During Trigger Point Injection
NCT06140368
The Effect of Virtual Reality on Pain and Anxiety in Patients Undergoing Upper Endoscopy
NCT06159829
Virtual Reality Distraction for Pain and Anxiety in Hemodialysis Patients
NCT07334522
VR Therapy Effects in Lumbar Disc Herniation
NCT07309627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immersive Virtual Reality
Individuals will wear the headset for 10 minutes while playing NatureTrek application
Immersive virtual reality
Oculus Quest 2 will be used with NatureTrek application for 10 minutes.
Non-immersive Virtual Reality
Individuals will watch a video including scenes from NatureTrek application for 10 minutes.
Non-immersive virtual reality
Patients will watch a video including scenes from NatureTrek application on a screen.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immersive virtual reality
Oculus Quest 2 will be used with NatureTrek application for 10 minutes.
Non-immersive virtual reality
Patients will watch a video including scenes from NatureTrek application on a screen.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right hand dominant,
Exclusion Criteria
* Any psychiatric and neurological diagnosis,
* Have a cognitive problem that prevents them from adapting to the working procedure,
* Using centrally acting medications and anti-depressants.
* Presence of neuropathic pain,
* Presence of vision or hearing problems,
* Any psychiatric and neurological diagnosis
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kartal Dr. Lütfi Kirdar City Hospital
UNKNOWN
Acibadem University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acıbadem Mehmet Ali Aydınlar University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATADEK 2022-14/06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.